ORBIMED ADVISORS LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$7.8B
Holdings
129
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (129 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —TESARO INC | 47,200 | $6.3B | 80.87% | |
| 102 | SIENUSDSIENTRA INC | 742,574 | $6.3B | 80.62% | |
| 103 | —AFFIMED N V | 3,375,000 | $6.1B | 77.41% | |
| 104 | —AEGERION PHARMACEUTICALS INC | 8,000,000 | $6.0B | 76.15% | |
| 105 | CLLSCELLECTIS S A | 350,000 | $5.9B | 75.60% | |
| 106 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,360,224 | $5.9B | 75.39% | |
| 107 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $5.9B | 75.29% | |
| 108 | SNDXSYNDAX PHARMACEUTICALS INC | 757,365 | $5.4B | 69.19% | |
| 109 | ZBHZIMMER BIOMET HLDGS INC | 49,000 | $5.1B | 64.44% | |
| 110 | INFIQINFINITY PHARMACEUTICALS INC | 3,250,300 | $4.4B | 55.91% | |
| 111 | —ROKA BIOSCIENCE INC | 893,470 | $3.8B | 48.27% | |
| 112 | NVTA1EURINVITAE CORP | 456,666 | $3.6B | 46.20% | |
| 113 | AMEDAMEDISYS INC | 71,500 | $3.0B | 38.84% | |
| 114 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 724,184 | $2.9B | 37.37% | |
| 115 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $2.8B | 36.06% | |
| 116 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 300,000 | $2.7B | 34.17% | |
| 117 | PTCTPTC THERAPEUTICS INC | 204,400 | $2.2B | 28.41% | |
| 118 | GBYSANGAMO BIOSCIENCES INC | 707,400 | $2.2B | 27.50% | |
| 119 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $1.5B | 18.67% | |
| 120 | AMRNAMARIN CORP PLC | 350,000 | $1.1B | 13.74% | |
| 121 | —BIOLINERX LTD | 1,038,600 | $956.0M | 12.18% | |
| 122 | —NOVELION THERAPEUTICS INC | 100,000 | $842.0M | 10.73% | |
| 123 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $589.0M | 7.51% | |
| 124 | —MARINUS PHARMACEUTICALS INC | 567,600 | $573.0M | 7.30% | |
| 125 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $562.0M | 7.16% | |
| 126 | —MEDIGUS LTD | 600,000 | $339.0M | 4.32% | |
| 127 | —ARALEZ PHARMACEUTICALS INC | 68,143 | $301.0M | 3.84% | |
| 128 | —ALIMERA SCIENCES INC | 250,000 | $270.0M | 3.44% | |
| 129 | —XTANT MED HLDGS INC | 475,439 | $261.0M | 3.33% |
PreviousPage 2 of 2